. Author manuscript; available in PMC: 2019 Mar 1.

Published in final edited form as: Transplantation. 2018 Mar;102(3):502–509. doi: 10.1097/TP.0000000000001944

Table 6.

Comparing adverse outcomes of transplant between C1q+ DSA MFI <7000 And/or C1q− DSA MFI ≥7000 versus C1q− DSA MFI <7000 and/or C1q+ DSA MFI ≥7000.

				p value^a
Adverse outcome variable	No DSA (N=68)	C1q+ DSA MFI <7000 And C1q− DSA MFI ≥7000 (N=11)	C1q− DSA MFI <7000 And C1q+ DSA MFI ≥7000 (N=48)	No DSA Vs C1q+ DSA MFI <7000 And/or C1q− DSA MFI ≥7000	No DSA Vs C1q− DSA MFI <7000 And/or C1q+DSA MFI ≥7000	C1q+DSA MFI <7000 And/or C1q−DSA MFI ≥ 7000 Vs C1q−DSA MFI <7000 And/or C1q+ DSA MFI ≥ 7000
Acute rejections	0.5±0.9	1.8±1.1	1.4±1.4	<0.0001§	0.0002§	0.479§
CAV	8 (11.7%)	4 (36.3%)	17 (35.4%)	0.0574*	0.0014	1.000*
Graft Loss (acute rejections and/or CAV)	12 (17.6%)	6 (54.5%)	9 (18.75%)	0.0259*	0.893	0.0274*

Note:

§ by t test; * by Fisher’s Exact Test; Otherwise by Chi Square Test